Fig. 8
Graphic Abstract: Combination of WGCNA, network pharmacology and molecular docking identifies CDKN2A as a crucial target of CWQ in CRC treatment
Fig. 8 | Hereditas
Graphic Abstract: Combination of WGCNA, network pharmacology and molecular docking identifies CDKN2A as a crucial target of CWQ in CRC treatment